Dendritic Cell Therapy has shown promise in treating various types of cancer, including melanoma, prostate cancer, and certain types of lymphoma. One of the most well-known applications is in the treatment of prostate cancer, specifically through a product known as Provenge, which was the first FDA-approved dendritic cell-based vaccine.
